Skip to main content
Literatur
1.
Zurück zum Zitat Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M et al (2017) Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol 65:147–156CrossRef Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M et al (2017) Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol 65:147–156CrossRef
2.
Zurück zum Zitat Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M et al (2001) Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosom Cancer 32:302–310CrossRef Fioretos T, Panagopoulos I, Lassen C, Swedin A, Billström R, Isaksson M et al (2001) Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL. Genes Chromosom Cancer 32:302–310CrossRef
3.
Zurück zum Zitat Barnes EJ, Leonard J, Medeiros BC, Druker BJ, Tognon CE (2020) Functional characterization of two rare BCR-FGFR1+ leukemias. Cold Spring Harb Mol Case Stud 6:a004838CrossRef Barnes EJ, Leonard J, Medeiros BC, Druker BJ, Tognon CE (2020) Functional characterization of two rare BCR-FGFR1+ leukemias. Cold Spring Harb Mol Case Stud 6:a004838CrossRef
4.
Zurück zum Zitat Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G et al (2020) NARASIMHA: novel assay based on targeted RNA sequencing to identify chimeric gene fusions in hematological malignancies. Blood Cancer J 10:50CrossRef Patkar N, Bhanshe P, Rajpal S, Joshi S, Chaudhary S, Chatterjee G et al (2020) NARASIMHA: novel assay based on targeted RNA sequencing to identify chimeric gene fusions in hematological malignancies. Blood Cancer J 10:50CrossRef
5.
Zurück zum Zitat Peiris MN, Meyer AN, Nelson KN, Bisom-Rapp EW, Donoghue DJ (2020) Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation. Haematologica 105(5):1262–1273CrossRef Peiris MN, Meyer AN, Nelson KN, Bisom-Rapp EW, Donoghue DJ (2020) Oncogenic fusion protein BCR-FGFR1 requires the breakpoint cluster region-mediated oligomerization and chaperonin Hsp90 for activation. Haematologica 105(5):1262–1273CrossRef
Metadaten
Titel
Myeloid Neoplasm with t(8;22)(p11;q11): A Mimicker of Chronic Myeloid Leukaemia in Blast Crisis
verfasst von
Gargi Kapatia
Arun Sasikumar Nair Remani
Shano Naseem
Mayur Parihar
Sreejesh Sreedharanunni
Publikationsdatum
31.08.2020
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2021
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01343-3

Weitere Artikel der Ausgabe 2/2021

Indian Journal of Hematology and Blood Transfusion 2/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.